Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$2.05 - $8.14 $1,439 - $5,714
702 Added 95.77%
1,435 $3,000
Q3 2023

Oct 30, 2023

BUY
$2.05 - $8.14 $1,439 - $5,714
702 Added 95.77%
1,435 $3,000
Q2 2023

May 21, 2024

SELL
$4.99 - $7.64 $124 - $191
-25 Reduced 3.3%
733 $4,000
Q2 2023

Jul 27, 2023

SELL
$4.99 - $7.64 $124 - $191
-25 Reduced 3.3%
733 $5,000
Q1 2023

May 21, 2024

BUY
$5.5 - $9.77 $1,045 - $1,856
190 Added 33.45%
758 $4,000
Q1 2023

Apr 27, 2023

BUY
$5.5 - $9.77 $1,045 - $1,856
190 Added 33.45%
758 $4,000
Q4 2022

May 21, 2024

BUY
$7.86 - $17.2 $4,464 - $9,769
568 New
568 $5,000
Q4 2022

Jan 31, 2023

BUY
$7.86 - $17.2 $353 - $774
45 Added 8.6%
568 $6,000
Q3 2022

Oct 21, 2022

BUY
$14.09 - $25.57 $7,369 - $13,373
523 New
523 $9,000

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $347M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.